Both protein re-distribution scenarios discussed here have been described in gynecologic malignancies and may play a role as prognosticators in these cancers; beta-catenin in endometrial cancer and CapG in breast and ovarian cancer. This evidence concerns the gene CTNNB1 and ovarian cancer.